In a UK Biobank secondary analysis using LiverMultiScan, variants in glycogen-metabolism genes associated with MRI-PDFF were not linked to NAFLD risk, suggesting hepatic glycogen can bias PDFF and should be considered when interpreting MRI-based liver fat measurements.